Premium
HCV and nonhepatic malignancy: Is pre‐emptive direct‐acting antiviral therapy indicated prior to treatment?
Author(s) -
Kriss Michael,
Burchill Matthew
Publication year - 2018
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.29414
Subject(s) - medicine , malignancy , hepatitis c virus , hepatitis c , antiviral therapy , hepacivirus , virology , oncology , chronic hepatitis , virus